Page last updated: 2024-09-02

saikosaponin d and Bone Loss, Osteoclastic

saikosaponin d has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, H; Chen, L; Fang, X; Lu, F; Song, X; Sun, J; Wu, X; Zhang, W; Zhao, K	1

Other Studies

1 other study(ies) available for saikosaponin d and Bone Loss, Osteoclastic

Article	Year
Inhibition of Lipopolysaccharide-Induced Inflammatory Bone Loss by Saikosaponin D is Associated with Regulation of the RANKL/RANK Pathway. Drug design, development and therapy, 2021, Volume: 15 Topics: Animals; Anti-Inflammatory Agents; Bone Resorption; Cell Differentiation; Cells, Cultured; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Oleanolic Acid; Osteoclasts; Osteogenesis; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Saponins	2021

Article

Year

Inhibition of Lipopolysaccharide-Induced Inflammatory Bone Loss by Saikosaponin D is Associated with Regulation of the RANKL/RANK Pathway.

Drug design, development and therapy, 2021, Volume: 15

Topics: Animals; Anti-Inflammatory Agents; Bone Resorption; Cell Differentiation; Cells, Cultured; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Oleanolic Acid; Osteoclasts; Osteogenesis; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Saponins

2021